Showing results (1-10 of 38) with videos related to
Sort By:
Pageof 4
Annals of the New York Academy of Sciences|September 16, 2010
Hormonal contraception in obesity, the metabolic syndrome, and diabetesSven O SkoubyHormone Molecular Biology and Clinical Investigation|November 18, 2018
Impact of progestogens on hemostasisSven O Skouby, Johannes J SidelmannHormone Molecular Biology and Clinical Investigation|February 20, 2021
What is the optimal luteal support in assisted reproductive technology?Nathalie F Wang, Leif Bungum, Sven O SkoubyMaturitas|February 23, 2007
The EMAS 2006/2007 update on clinical recommendations on postmenopausal hormone therapyAnne Gompel, David Barlow, Serge Rozenberg, et al.Maturitas|May 9, 2006
Updating the EMAS 2004/2005 clinical recommendations on postmenopausal therapy following the recent publications: WHI and Nurses' Health StudyAnne Gompel, David Barlow, Serge Rozenberg, et al.Human Reproduction (Oxford, England)|January 6, 2007
A comparative study of the effect of continuous combined conjugated equine estrogen plus medroxyprogesterone acetate and tibolone on blood coagulabilitySven O Skouby, Johannes J Sidelmann, Lisbeth Nilas, et al.Endocrine Connections|January 4, 2018
Effect of liraglutide on atrial natriuretic peptide, adrenomedullin, and copeptin in PCOSSigne Frøssing, Malin Nylander, Caroline Kistorp, et al.Endocrine Connections|January 26, 2017
Liraglutide in polycystic ovary syndrome: a randomized trial, investigating effects on thrombogenic potentialMalin Nylander, Signe Frøssing, Caroline Kistorp, et al.Annals of Medicine|July 1, 2004
Estrogen replacement therapy in combination with continuous intrauterine progestin administration reduces the amount of circulating oxidized LDL in postmenopausal women: dependence on the dose of progestinMarkku Ahotupa, Ilkka Rauramo, Tommi J Vasankari, et al.Pageof 4